Quantifying remission probability in type 2 diabetes mellitus

5Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic progressive disorder and is associated with significant morbidity and mortality. The concept of T2DM remission and the reversal of diabetic parameters to normal levels has been gaining momentum over the past years. T2DM remission is increasingly being recognized by various global guidelines. Multiple models have been developed and validated for quantifying the extent of remission achieved. Based on favorable clinical evidence, T2DM remission can be considered as the therapeutic goal in diabetes management and, in select cases, as an alternative to expensive treatment options, which can be burdensome as T2DM progresses. This narrative review discusses the available strategies, such as lifestyle interventions, physical activity, bariatric surgery, medical nutrition therapy, and non-insulin glucose-lowering medications, for achieving T2DM remission. Although the concept of T2DM remission has emerged as a real-world option, effective implementation in routine clinical practice may not be feasible until long-term studies prove the efficacy of different approaches in this regard.

Cite

CITATION STYLE

APA

Kalra, S., Bantwal, G., Kapoor, N., Sahay, R., Bhattacharya, S., Anne, B., … Das, A. K. (2021, December 1). Quantifying remission probability in type 2 diabetes mellitus. Clinics and Practice. Page Press Publications. https://doi.org/10.3390/clinpract11040100

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free